Status:
ENROLLING_BY_INVITATION
IMProving Adherence to Colonoscopy Through Teams and Technology
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Colon Cancer
Cancer Colorectal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Complete and timely colonoscopy after an abnormal stool-based colorectal cancer screening test results in early detection, cancer prevention, and reduction in mortality, but follow-up in safety-net he...
Detailed Description
Follow-up colonoscopy after abnormal stool-based colorectal cancer screening (e.g., fecal immunochemical test (FIT)) results in early detection of colorectal cancer (CRC), prevention of CRC, and reduc...
Eligibility Criteria
Inclusion
- Patients with abnormal FIT result
- Patients ages 18 years or older
- English, Spanish, or Cantonese speaking
Exclusion
- Patients with normal FIT result
- Patients younger than age 18
Key Trial Info
Start Date :
July 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06191185
Start Date
July 8 2024
End Date
March 1 2027
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuckerberg San Francisco General Hospital
San Francisco, California, United States, 94110